基于优势因子评判算法的肝癌18F-FDG PET/CT动力学参数估计。

IF 3.2 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Medical physics Pub Date : 2025-04-23 DOI:10.1002/mp.17851
Jianfeng He, Siming Li, Yiwei Xiong, Yu Yao, Siyu Wang, Sidan Wang, Shaobo Wang
{"title":"基于优势因子评判算法的肝癌18F-FDG PET/CT动力学参数估计。","authors":"Jianfeng He,&nbsp;Siming Li,&nbsp;Yiwei Xiong,&nbsp;Yu Yao,&nbsp;Siyu Wang,&nbsp;Sidan Wang,&nbsp;Shaobo Wang","doi":"10.1002/mp.17851","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Kinetic parameters estimated with dynamic <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET)/computed tomography (CT) help characterize hepatocellular carcinoma (HCC), and deep reinforcement learning (DRL) can improve kinetic parameter estimation.</p>\n </section>\n \n <section>\n \n <h3> Purpose</h3>\n \n <p>The advantage actor-critic (A2C) algorithm is a DRL algorithm with neural networks that seek the optimal parameters. The aim of this study was to preliminarily assess the role of the A2C algorithm in estimating the kinetic parameters of <sup>18</sup>F-FDG PET/CT in patients with HCC.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p><sup>18</sup>F-FDG PET data from 14 liver tissues and 17 HCC tumors obtained via a previously developed, abbreviated acquisition protocol (5-min dynamic PET/CT imaging supplemented with 1-min static imaging at 60 min) were prospectively collected. The A2C algorithm was used to estimate kinetic parameters with a reversible double-input, three-compartment model, and the results were compared with those of the conventional nonlinear least squares (NLLS) algorithm. Fitting errors were compared via the root-mean-square errors (RMSEs) of the time activity curves (TACs).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Significant differences in <i>K</i><sub>1</sub>, <i>k</i><sub>2</sub>, <i>k</i><sub>3</sub>, <i>k</i><sub>4</sub>, <i>f<sub>a</sub></i>, and <i>v<sub>b</sub></i> according to the A2C algorithm and <i>k</i><sub>3</sub>, <i>f<sub>a</sub></i>, and <i>v<sub>b</sub></i> according to the NLLS algorithm were detected between HCC and normal liver tissues (all <i>p &lt;</i> 0.05). Furthermore, A2C demonstrated superior diagnostic performance over NLLS in terms of <i>k</i><sub>3</sub> and <i>v<sub>b</sub></i> (both <i>p &lt;</i> 0.05 in the Delong test). Notably, A2C yielded a smaller fitting error for normal liver tissue (0.62 ± 0.24 vs. 1.04 ± 1.00) and HCC tissue (1.40 ± 0.42 vs. 1.51 ± 0.97) than did NLLS.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Compared with the conventional postreconstruction NLLS method, the A2C algorithm can more precisely estimate <sup>18</sup>F-FDG kinetic parameters with a reversible double-input, three-compartment model for HCC tumors, attaining better TAC fitting with a lower RMSE.</p>\n </section>\n </div>","PeriodicalId":18384,"journal":{"name":"Medical physics","volume":"52 7","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatocellular carcinoma 18F-FDG PET/CT kinetic parameter estimation based on the advantage actor-critic algorithm\",\"authors\":\"Jianfeng He,&nbsp;Siming Li,&nbsp;Yiwei Xiong,&nbsp;Yu Yao,&nbsp;Siyu Wang,&nbsp;Sidan Wang,&nbsp;Shaobo Wang\",\"doi\":\"10.1002/mp.17851\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Kinetic parameters estimated with dynamic <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET)/computed tomography (CT) help characterize hepatocellular carcinoma (HCC), and deep reinforcement learning (DRL) can improve kinetic parameter estimation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Purpose</h3>\\n \\n <p>The advantage actor-critic (A2C) algorithm is a DRL algorithm with neural networks that seek the optimal parameters. The aim of this study was to preliminarily assess the role of the A2C algorithm in estimating the kinetic parameters of <sup>18</sup>F-FDG PET/CT in patients with HCC.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Materials and Methods</h3>\\n \\n <p><sup>18</sup>F-FDG PET data from 14 liver tissues and 17 HCC tumors obtained via a previously developed, abbreviated acquisition protocol (5-min dynamic PET/CT imaging supplemented with 1-min static imaging at 60 min) were prospectively collected. The A2C algorithm was used to estimate kinetic parameters with a reversible double-input, three-compartment model, and the results were compared with those of the conventional nonlinear least squares (NLLS) algorithm. Fitting errors were compared via the root-mean-square errors (RMSEs) of the time activity curves (TACs).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Significant differences in <i>K</i><sub>1</sub>, <i>k</i><sub>2</sub>, <i>k</i><sub>3</sub>, <i>k</i><sub>4</sub>, <i>f<sub>a</sub></i>, and <i>v<sub>b</sub></i> according to the A2C algorithm and <i>k</i><sub>3</sub>, <i>f<sub>a</sub></i>, and <i>v<sub>b</sub></i> according to the NLLS algorithm were detected between HCC and normal liver tissues (all <i>p &lt;</i> 0.05). Furthermore, A2C demonstrated superior diagnostic performance over NLLS in terms of <i>k</i><sub>3</sub> and <i>v<sub>b</sub></i> (both <i>p &lt;</i> 0.05 in the Delong test). Notably, A2C yielded a smaller fitting error for normal liver tissue (0.62 ± 0.24 vs. 1.04 ± 1.00) and HCC tissue (1.40 ± 0.42 vs. 1.51 ± 0.97) than did NLLS.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Compared with the conventional postreconstruction NLLS method, the A2C algorithm can more precisely estimate <sup>18</sup>F-FDG kinetic parameters with a reversible double-input, three-compartment model for HCC tumors, attaining better TAC fitting with a lower RMSE.</p>\\n </section>\\n </div>\",\"PeriodicalId\":18384,\"journal\":{\"name\":\"Medical physics\",\"volume\":\"52 7\",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mp.17851\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical physics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mp.17851","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

背景:动态18f -氟脱氧葡萄糖(18F-FDG)正电子发射断层扫描(PET)/计算机断层扫描(CT)估计的动力学参数有助于表征肝细胞癌(HCC),而深度强化学习(DRL)可以改善动力学参数估计。目的:A2C算法是一种利用神经网络寻求最优参数的DRL算法。本研究的目的是初步评估A2C算法在HCC患者18F-FDG PET/CT动力学参数估计中的作用。材料和方法:前瞻性收集来自14个肝组织和17个HCC肿瘤的18F-FDG PET数据,这些数据是通过先前开发的简化获取方案(5分钟动态PET/CT成像辅以60分钟静态成像1分钟)获得的。采用A2C算法对可逆双输入三室模型进行动力学参数估计,并与传统非线性最小二乘(NLLS)算法的结果进行比较。通过时间活动曲线(TACs)的均方根误差(rmse)比较拟合误差。结果:HCC与正常肝组织之间,A2C算法的K1、k2、k3、k4、fa、vb与NLLS算法的k3、fa、vb均存在显著差异(均为p3、vb均为p)。结论:与传统的构建后NLLS方法相比,A2C算法可以更精确地估计肝癌肿瘤的18F-FDG动力学参数,具有可逆的双输入、三室模型,获得更好的TAC拟合,RMSE更低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hepatocellular carcinoma 18F-FDG PET/CT kinetic parameter estimation based on the advantage actor-critic algorithm

Background

Kinetic parameters estimated with dynamic 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) help characterize hepatocellular carcinoma (HCC), and deep reinforcement learning (DRL) can improve kinetic parameter estimation.

Purpose

The advantage actor-critic (A2C) algorithm is a DRL algorithm with neural networks that seek the optimal parameters. The aim of this study was to preliminarily assess the role of the A2C algorithm in estimating the kinetic parameters of 18F-FDG PET/CT in patients with HCC.

Materials and Methods

18F-FDG PET data from 14 liver tissues and 17 HCC tumors obtained via a previously developed, abbreviated acquisition protocol (5-min dynamic PET/CT imaging supplemented with 1-min static imaging at 60 min) were prospectively collected. The A2C algorithm was used to estimate kinetic parameters with a reversible double-input, three-compartment model, and the results were compared with those of the conventional nonlinear least squares (NLLS) algorithm. Fitting errors were compared via the root-mean-square errors (RMSEs) of the time activity curves (TACs).

Results

Significant differences in K1, k2, k3, k4, fa, and vb according to the A2C algorithm and k3, fa, and vb according to the NLLS algorithm were detected between HCC and normal liver tissues (all p < 0.05). Furthermore, A2C demonstrated superior diagnostic performance over NLLS in terms of k3 and vb (both p < 0.05 in the Delong test). Notably, A2C yielded a smaller fitting error for normal liver tissue (0.62 ± 0.24 vs. 1.04 ± 1.00) and HCC tissue (1.40 ± 0.42 vs. 1.51 ± 0.97) than did NLLS.

Conclusions

Compared with the conventional postreconstruction NLLS method, the A2C algorithm can more precisely estimate 18F-FDG kinetic parameters with a reversible double-input, three-compartment model for HCC tumors, attaining better TAC fitting with a lower RMSE.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medical physics
Medical physics 医学-核医学
CiteScore
6.80
自引率
15.80%
发文量
660
审稿时长
1.7 months
期刊介绍: Medical Physics publishes original, high impact physics, imaging science, and engineering research that advances patient diagnosis and therapy through contributions in 1) Basic science developments with high potential for clinical translation 2) Clinical applications of cutting edge engineering and physics innovations 3) Broadly applicable and innovative clinical physics developments Medical Physics is a journal of global scope and reach. By publishing in Medical Physics your research will reach an international, multidisciplinary audience including practicing medical physicists as well as physics- and engineering based translational scientists. We work closely with authors of promising articles to improve their quality.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信